Galloflavin / Glycolysis Cancer Research Results

Gallo, Galloflavin: Click to Expand ⟱
Features:
Galloflavin is a flavonoid compound found in certain plants, such as the Galphimia gracilis. Studies have demonstrated that galloflavin can inhibit the growth of cancer cells and induce apoptosis (cell death) in various types of cancer, including breast, lung, and colon cancer. Galloflavin's anti-cancer effects are thought to be due to its ability to modulate various cellular signaling pathways, including the PI3K/Akt and NF-κB pathways, which are involved in cell survival and proliferation. Additionally, galloflavin has been shown to have antioxidant and anti-inflammatory properties, which may also contribute to its anti-cancer effects.

Galloflavin has been reported to be a lactate dehydrogenase (LDH) inhibitor. LDH is an enzyme that plays a crucial role in the metabolism of cancer cells, particularly in the process of glycolysis, which is the breakdown of glucose to produce energy.
Galloflavin's LDH inhibitory activity has been demonstrated in various studies, which have shown that it can inhibit LDH activity in cancer cells, leading to a decrease in lactate production and an increase in the production of reactive oxygen species (ROS). The increase in ROS can lead to cell death, making galloflavin a potential therapeutic agent for the treatment of cancer.
Galloflavin is unusually clean mechanistically:
-LDH-A inhibition is the primary molecular target
-Everything else (↓ lactate, NAD⁺ stress, ROS, mitochondrial dependence) is downstream
-Apoptosis and tumor suppression are consequences, not drivers
This makes galloflavin one of the best-defined Warburg-effect inhibitors.

Not use if antitumor effect extends to in vivo?
Rank Pathway / Target Axis Direction Primary Effect Notes / Cancer Relevance Ref
1 Lactate dehydrogenase (LDH-A and LDH-B) ↓ LDH activity Warburg glycolysis inhibition Galloflavin directly inhibits both isoforms of LDH, blocking the conversion of pyruvate to lactate and impairing glycolytic flux in tumor cells. :contentReference[oaicite:1]{index=1} (ref)
2 Glycolysis output / ATP synthesis ↓ lactate production & ATP Reduced cancer cell energy Galloflavin blocks aerobic glycolysis in multiple tumor cell lines, reducing lactate and ATP, and thus limiting energy available for proliferation. :contentReference[oaicite:2]{index=2} (ref)
3 Cell proliferation ↓ proliferation / growth Growth suppression Galloflavin inhibits proliferation across several cancer cell models (breast cancer MCF-7, MDA-MB-231, and tamoxifen-resistant cells), independent of glycolytic phenotype. :contentReference[oaicite:3]{index=3} (ref)
4 Apoptosis induction ↑ apoptosis (caspase activation) Programmed cell death Breast cancer work shows galloflavin induces apoptosis as the main mode of cell death, with signaling differences depending on glycolytic status. :contentReference[oaicite:4]{index=4} (ref)
5 Reactive oxygen species (ROS) ↑ ROS Oxidative stress Endometrial cancer cells treated with galloflavin show increased ROS production, potentially contributing to cytotoxicity and DNA damage. :contentReference[oaicite:5]{index=5} (ref)
6 Mitochondrial apoptosis axis (Bcl-2/MCL-1 changes) ↑ mitochondrial apoptosis Execution-phase cell death In endometrial cancer cells, galloflavin increases markers of mitochondrial apoptosis (e.g., cleaved caspase-3) while lowering anti-apoptotic proteins Bcl-2 and Mcl-1. :contentReference[oaicite:6]{index=6} (ref)
7 Cell cycle regulation ↑ cell-cycle arrest Proliferation blockade GF induces cell-cycle changes in endometrial cancer models (e.g., G2 arrest in some lines), indicating impacts on proliferation checkpoints. :contentReference[oaicite:7]{index=7} (ref)
8 Metastasis-related markers (E-cadherin / Slug) ↑ E-cadherin / ↓ Slug Reduced invasive phenotype Galloflavin treatment increases E-cadherin and decreases Slug in endometrial cancer cells, consistent with reduced migratory/invasive capacity. :contentReference[oaicite:8]{index=8} (ref)
9 LDH-A binding to ssDNA & RNA synthesis ↓ LDH-A-ssDNA binding & ↓ RNA synthesis Transcription/stress axis Galloflavin prevents LDHA binding to single-stranded DNA and inhibits RNA synthesis independently of glycolysis. :contentReference[oaicite:9]{index=9} (ref)
10 Combinatorial metabolic inhibition (in vitro) ↑ metabolic stress when combined Enhanced anti-proliferative effect In vitro work shows galloflavin enhances antiproliferative and apoptotic effects in combination with other metabolic inhibitors (e.g., CPI-613) in pancreatic cancer cells. :contentReference[oaicite:10]{index=10} (ref)


Glycolysis, Glycolysis: Click to Expand ⟱
Source:
Type:
Glycolysis is a metabolic pathway that converts glucose into pyruvate, producing a small amount of ATP (energy) in the process. It is a fundamental process for cellular energy production and occurs in the cytoplasm of cells. In normal cells, glycolysis is tightly regulated and is followed by aerobic respiration in the presence of oxygen, which allows for the efficient production of ATP.
In cancer cells, however, glycolysis is often upregulated, even in the presence of oxygen. This phenomenon is known as the Warburg Mutations in oncogenes (like MYC) and tumor suppressor genes (like TP53) can alter metabolic pathways, promoting glycolysis and other anabolic processes that support cell growth.effect.
Acidosis: The increased production of lactate from glycolysis can lead to an acidic microenvironment, which may promote tumor invasion and suppress immune responses.

Glycolysis is a hallmark of malignancy transformation in solid tumor, and LDH is the key enzyme involved in glycolysis.

Pathways:
-GLUTs, HK2, PFK, PK, PKM2, LDH, LDHA, PI3K/AKT/mTOR, AMPK, HIF-1a, c-MYC, p53, SIRT6, HSP90α, GAPDH, HBT, PPP, Lactate Metabolism, ALDO

Natural products targeting glycolytic signaling pathways https://pmc.ncbi.nlm.nih.gov/articles/PMC9631946/
Alkaloids:
-Berberine, Worenine, Sinomenine, NK007, Tetrandrine, N-methylhermeanthidine chloride, Dauricine, Oxymatrine, Matrine, Cryptolepine

Flavonoids: -Oroxyline A, Apigenin, Kaempferol, Quercetin, Wogonin, Baicalein, Chrysin, Genistein, Cardamonin, Phloretin, Morusin, Bavachinin, 4-O-methylalpinumisofavone, Glabridin, Icaritin, LicA, Naringin, IVT, Proanthocyanidin B2, Scutellarin, Hesperidin, Silibinin, Catechin, EGCG, EGC, Xanthohumol.

Non-flavonoid phenolic compounds:
Curcumin, Resveratrol, Gossypol, Tannic acid.

Terpenoids:
-Cantharidin, Dihydroartemisinin, Oleanolic acid, Jolkinolide B, Cynaropicrin, Ursolic Acid, Triptolie, Oridonin, Micheliolide, Betulinic Acid, Beta-escin, Limonin, Bruceine D, Prosapogenin A (PSA), Oleuropein, Dioscin.

Quinones:
-Thymoquinone, Lapachoi, Tan IIA, Emodine, Rhein, Shikonin, Hypericin

Others:
-Perillyl alcohol, HCA, Melatonin, Sulforaphane, Vitamin D3, Mycoepoxydiene, Methyl jasmonate, CK, Phsyciosporin, Gliotoxin, Graviola, Ginsenoside, Beta-Carotene.
Scientific Papers found: Click to Expand⟱
934- Gallo,    Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase
- Analysis, NA, NA
LDH↓, Glycolysis↓, Apoptosis↑,
935- Gallo,    Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways
- in-vitro, BC, MCF-7 - in-vitro, BC, MDA-MB-231
LDH↓, ROS↑, TumCP↓, Glycolysis↓, ATP↓, ER-α36↓, Apoptosis?,
5205- Gallo,    Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells
- in-vitro, Endo, ISH
LDH↓, TumCG↓, LDHA↓, Apoptosis↑, cl‑Casp3↑, Mcl-1↓, Bcl-2↓, TumCCA↑, ROS↑, mt-DNAdam↑, GlucoseCon↓, ATP↓, PDH↑, Pyruv↑, Glycolysis↓, TCA↑, cMyc↓, E-cadherin↑, Slug↓,
5206- Gallo,    Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells
- in-vitro, Var, NA
LDHA↓, Glycolysis↓, TumCP↓,

Showing Research Papers: 1 to 4 of 4

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

ROS↑, 2,  

Mitochondria & Bioenergetics ⓘ

ATP↓, 2,  

Core Metabolism/Glycolysis ⓘ

cMyc↓, 1,   GlucoseCon↓, 1,   Glycolysis↓, 4,   LDH↓, 3,   LDHA↓, 2,   PDH↑, 1,   Pyruv↑, 1,   TCA↑, 1,  

Cell Death ⓘ

Apoptosis?, 1,   Apoptosis↑, 2,   Bcl-2↓, 1,   cl‑Casp3↑, 1,   Mcl-1↓, 1,  

DNA Damage & Repair ⓘ

mt-DNAdam↑, 1,  

Cell Cycle & Senescence ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

TumCG↓, 1,  

Migration ⓘ

E-cadherin↑, 1,   ER-α36↓, 1,   Slug↓, 1,   TumCP↓, 2,  

Clinical Biomarkers ⓘ

LDH↓, 3,  
Total Targets: 23

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: Glycolysis, Glycolysis
4 Galloflavin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:177  Target#:129  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page